Human Phenotype Ontology 
Grandparent Node:
expandAbnormality of the coagulation cascade (HP:0003256)help
Parent Node:
expandAbnormality of the common coagulation pathway (HP:0010990)help
..Starting node
..expandIncreased plasma vitamin K epoxide after vitamin K supplementation (HP:0040239)help
Term ID: 40239
Name: Increased plasma vitamin K epoxide after vitamin K supplementation
Synonym:
Definition: Increased plasma vitamin K epoxide after vitamin K supplementation is present in VKCFD (vitamin K-dependent clotting factor deficiency) type 2, but not in VKCFD type 1.
Comments:
Reference: HP:0040239
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAbnormal coagulation factor V activity (HP:0031899) help
..expandAbnormality of circulating fibrinogen (HP:0011898) help
..expandDecreased level of heparin co-factor II (HP:0040226) help
..expandDecreased level of histidine-rich glycoprotein (HP:0040227) help
..expandDecreased level of plasminogen (HP:0040228) help
..expandDecreased level of thrombomodulin (HP:0040229) help
..expandDecreased level of tissue plasminogen activator (HP:0040230) help
..expandProlonged Russell's viper venom time (HP:0040244) help
..expandReduced alpha-2-antiplasmin activity (HP:0040245) help
..expandReduced antithrombin antigen (HP:0040246) help
..expandReduced factor X activity (HP:0008321) help
..expandReduced factor XIII activity (HP:0008357) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0040239HP:0040239Increased plasma vitamin K epoxide after vitamin K supplementation0 CL E G H


Genes (0) :

Diseases (0) :
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.